Expanded Surveillance for Pediatric Infectious Diseases
View forecast on Grants.gov →Forecasted — not yet open
- Posted
- July 28, 2026
- Closes
- See announcement
- Award ceiling
- $1,140,000
- Award floor
- $850,000
- Program funding
- $40,000,000
- Expected awards
- 7
- Cost sharing
- No
- Instrument
- Cooperative Agreement
- Assistance listing
- 93.083
- Category
- Health
- Archives
- January 30, 2027
Program funding history
Awards made under Assistance Listing 93.083 across FY2024–FY2026, from public federal spending records.
- FY2024 obligated
- $0
- FY2025 obligated
- $3.4M
- FY2026 (to date) obligated
- $1M
- Awards in window
- 30
Top recipients: State of Alaska Department of Health, American Cancer Society, Inc, American Academy of Pediatrics, Florida Department of Health, Health, New Jersey Department of
Source: USAspending.gov · refreshed August 2026
Synopsis
The purpose of this Notice of Funding Opportunity (NOFO) is to support a network of U.S. institutions that will conduct standardized, prospective, active surveillance of pediatric acute respiratory illness (ARI) and acute gastroenteritis (AGE). The network will focus on respiratory and enteric viruses among pediatric patients seeking healthcare.
In addition, the network will generate robust estimates of the effectiveness of influenza, rotavirus, respiratory syncytial virus (RSV) and other prevention products against respiratory and enteric viral illnesses in this population.
Recipients will identify AGE and ARI illnesses among patients seeking healthcare or diagnostic testing for acute illness among inpatient and emergency department populations. Recipients may also include patients seeking care in outpatient clinics, such as urgent care centers, as an optional activity.
This is a multi-component NOFO. You must apply for ComponentA (Core Component). You may also apply for one or more optional components.
Component A – Core Component (Required)
- Support inpatient and emergency department pediatric surveillance
- Follow the standardized protocol established by CDC
Optional Components
- Component B: Support outpatient pediatric surveillance
- Component C: Study immune response and infection
- Component D: Study immune response and immunization
Recipients will enroll patients meeting standard symptom criteria and confirm viral infections using approved molecular assays. The network will use the data to estimate prevention product effectiveness, hospitalization rates, and information on the natural history of medically attended diseases.
Findings of this NOFO will:
- Improve best practices for diagnosis and treatment protocols
- Inform prevention product recommendations
- Guide public health strategies
- Reduce viral illness-associated hospitalizations and healthcare utilization among children
Who can apply
- Public housing authorities/Indian housing authorities
- Independent school districts
- Public and State controlled institutions of higher education
- For profit organizations other than small businesses
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- City or township governments
- State governments
- Native American tribal governments (Federally recognized)
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Special district governments
- Native American tribal organizations (other than Federally recognized tribal governments)
- Private institutions of higher education
- County governments
How to apply
Applications go through the official government listing. Grants Radar links you straight to the source — applying is free.
New to federal funding? How to read an announcement · Who can apply · How grants work
Get grants like this every Tuesday — free
One email a week: the biggest new federal grants and what’s closing soon — the same list for everyone. Unsubscribe in one click.
Similar grants
- Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
- Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
- Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
Same-day alerts, matched to you
The free digest is weekly — the same list for everyone. Members get an alert the day a matching federal grant posts: we read every new Grants.gov posting and score it, personalized to your organization. Free for 30 days, then $19/mo founding rate locked for life — the rate holds while your subscription stays active (Terms). Card required, cancel any time before day 31.
See pricing